Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jul 8;19(1):121.
doi: 10.1186/s12890-019-0885-8.

Is incentive spirometry beneficial for patients with lung cancer receiving video-assisted thoracic surgery?

Chin-Jung Liu  1   2   3   4 , Wen-Chen Tsai  1   2 , Chia-Chen Chu  3   4   5 , Chih-Hsin Muo  6 , Wei-Sheng Chung  7   8   9
Affiliations

Is incentive spirometry beneficial for patients with lung cancer receiving video-assisted thoracic surgery?

Chin-Jung Liu et al. BMC Pulm Med. .

Abstract

Background: The effectiveness of Incentive spirometry (IS) in patients undergoing video-assisted thoracic surgery (VATS) remains lacking. We conducted a population-based study to investigate the effectiveness of IS on patients with lung cancers following VATS.

Methods: We identified patients newly diagnosed with lung cancer who underwent surgical resection by VATS or thoracotomy from the years 2000 to 2008 in the Longitudinal Health Insurance Database. Exposure variable was the use of IS during admission for surgical resection by VATS or thoracotomy. Primary outcomes included hospitalization cost, incidence of pneumonia, and length of hospital stay. Secondary outcomes included the frequency of emergency department (ED) visits and hospitalizations at 3-month, 6-month, and 12-month follow-ups after thoracic surgery.

Results: We analyzed 7549 patients with lung cancer undergoing surgical resection by VATS and thoracotomy. The proportion of patients who were subjected to IS was significantly higher in those who underwent thoracotomy than in those who underwent VATS (68.4% vs. 53.1%, P < 0.0001). After we controlled for potential covariates, the IS group significantly reduced hospitalization costs (- 524.5 USD, 95% confidence interval [CI] = - 982.6 USD - -66.4 USD) and the risk of pneumonia (odds ratio = 0.55, 95% CI = 0.32-0.95) compared to the non-IS group following VATS. No difference in ED visit frequency and hospitalization frequency at 3-month, 6-month, and 1-year follow-up was noted between the IS and the non-IS groups following VATS.

Conclusions: The use of IS in patients with lung cancers undergoing VATS may reduce hospitalization cost and the risk of pneumonia.

Keywords: Incentive spirometry; Lung cancer; Video-assisted thoracic surgery (VATS).

PubMed Disclaimer

Conflict of interest statement

All authors declare that they have no competing interest.

Figures

Fig. 1
Fig. 1
Flow diagram of the study patients
Fig. 2
Fig. 2
Proportion of IS use between patients undergoing VATS and thoracotomy
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Cancer Fact sheet N°297 Updated February 2015. [http://www.who.int/mediacentre/factsheets/fs297/en/].
    1. Chen Z, Fillmore CM, Hammerman PS, Kim CF, Wong KK. Non-small-cell lung cancers: a heterogeneous set of diseases. Nat Rev Cancer. 2014;14(8):535–546. doi: 10.1038/nrc3775. - DOI - PMC - PubMed
    1. Laursen LO, Petersen RH, Hansen HJ, Jensen TK, Ravn J, Konge L. Video-assisted thoracoscopic surgery lobectomy for lung cancer is associated with a lower 30-day morbidity compared with lobectomy by thoracotomy. Eur J Cardiothorac Surg. 2016;49(3):870–875. doi: 10.1093/ejcts/ezv205. - DOI - PubMed
    1. Whitson BA, Groth SS, Andrade RS, Maddaus MA, Habermann EB, D'Cunha J. Survival after lobectomy versus segmentectomy for stage I non-small cell lung cancer: a population-based analysis. Ann Thorac Surg. 2011;92(6):1943–1950. doi: 10.1016/j.athoracsur.2011.05.091. - DOI - PubMed
    1. West HJ, Vallières E, Schild SE. Management of stage I and stage II non-small cell lung cancer: UpToDate; 2016.

MeSH terms